The expression of programmed cell death ligand-1 (PD-L1) in rectal cancer is still poorly studied, but some authors have shown that radiotherapy can stimulate its expression, although its prognostic/predictive impact is still unknown [27,28,29,30]. The gene discussed is CD274; the disease is rectal cancer.